MichelleRheault University of MinnesotaUnited States

MichelleRheault
Dr. Rheault is a Professor of Pediatrics and Director of the Division of Pediatric Nephrology at the University of Minnesota. She is a clinical researcher in pediatric glomerular disease and Alport syndrome.
Institution

Day 2 - Monday April 15, 2024

Time Session
9 a.m.
10:30 a.m.
Genetics and Genomics of Rare Kidney Disease: ISN-Indian SN Joint Session
PaulaCoccia Chairperson paula.coccia@hospitalitaliano.org.arHospital Italianod de Buenos Aires Argentina
Shyam BihariBansal Chairperson India
  • Genomics of Rare Genetic Diseases: Experiences From India
    VinodScaria Speaker vinods@igib.inVishwanath Cancer Care Foundation & Indian Institute of Technology KanpurIndia
  • On the Way to Translate GWAS into Kidney Disease Mechanisms
    KrzysztofKiryluk Speaker Columbia UniversityUnited States
  • X-linked Kidney Disorders in Women
    MichelleRheault Speaker rheau002@umn.eduUniversity of MinnesotaUnited States
  • Prenatal/Preimplantation Genetic Diagnosis and Genetic Counseling for Genetic Kidney Disorders
    NineKnoers Speaker v.v.a.m.knoers@umcg.nlDepartment of Genetics, University Medical Centre Groningen, Groningen, The NetherlandsNetherlands
  • Q and A
Hall E
12:15 p.m.
1:15 p.m.
It
AlejandraOrozco Guillen Chairperson ale_gaba@hotmail.comNational Institute of Perinatology, Nephrology depMexico
IvanRychlik Chairperson ivan.rychlik@fnkv.czCharles University, Third Faculty of Medicine, Department of Internal MedicineCzech Republic
Rita MarcelaFortunato Chairperson marcelafortunator@gmail.comFundacion Favaloro University Hospital, Faculty of Medicine, University of Buenos AiresArgentina
  • Women and
    UrmilaAnandh Speaker uanandh@gmail.comAmrita Hospitals, Faridabad, Delhi NCRIndia
  • Pregnancy and CKD
    Prof LizLightstone Speaker Imperial College LondonUnited Kingdom
  • Pregnancy and Transplantation
    SilviShah Speaker University of Cincinnati, Ohio, United StatesUnited States
  • Global and African Epidemiology, Management and Outcomes of CKD and dialysis in Men and Women: A Perspective on Gender Disparities
    RashaDarwish Speaker Kasr Aleiny medical school , Cairo UniversityEgypt
  • Q and A
Hall C4
3 p.m.
4 p.m.
Late Breaking Clinical Trials Session
AlessiaFornoni Chairperson United States
MichelleRheault Chairperson rheau002@umn.eduUniversity of MinnesotaUnited States
  • Predicting the Risks of Kidney Failure and Death in Adults With Moderate-to-severe Chronic Kidney Disease (KDpredict)
    PietroRavani Free Communication pravani@ucalgary.caUniversity of CalgaryCanada
  • Plasma Exchange in ANCA Associated Vasculitis GN: Update After Pexivas
    Wladimir MietekSzpirt Speaker wladimir.mietek.szpirt.01@regionh.dkRigshospitalet, University of Copenhagen, Dept. of Nephrology, Denmark, Senior Research ConsultantDenmark
  • EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH IgA NEPHROPATHY: INTERIM RESULTS FROM THE PHASE 3 APPLAUSE-IgAN STUDY
    DanaRizk Free Communication drizk@uabmc.eduUniversity of Alabama at BirminghamUnited States
  • SPARSENTAN VS IRBESARTAN IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY (IgAN): SUBGROUP ANALYSES OF 2-YEAR RESULTS FROM THE PIVOTAL PHASE 3 PROTECT TRIAL
    JonathanBarratt Free Communication University of Leicester, Leicester, UKUnited Kingdom
  • PREGNANCY AMONG WOMEN ON CHRONIC DIALYSIS : THE FRENCH COHORT
    CécileCouchoud Free Communication cecile.couchoud@biomedecine.frREIN registry, Agence de la biomédecine, FranceFrance
Hall A